Revive Therapeutics Ltd C.RVV

Alternate Symbol(s): RVVTF

Healthcare Biotechnology

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

CSE:RVV - Post by User

Revive Therapeutics Ltd > It's time for FDA to EUA BUC now for God's sake !

<< Previous

Bullboard Posts

Next >>

Comment by 1ottrunneron Sep 27, 2021 10:43am

82 Views

Post# 33923689

RE:RE:RE:It's time for FDA to EUA BUC now for God's sake !

It looks promising? LOL

You idiots have no clue. This is science, nothing looks promising. It is or it isn't and until the trial results are posted it isn't anything!

cool888 wrote:

captainbrouwer wrote: Why do you say this when efficacy hasn't been demonstrated? Definitely looks promising and we hope it'll be effective but it's still hope at this point.

Agree !